Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KN01 (taurine) in A3243G-maternally inherited diabetes and deafness
jRCT2061190026Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in maternally inherited diabetes and deafness (MIDD) comparing Taurine (KN01) with Placebo (2 arms). Primary endpoint: HbA1c change from baseline. Started Apr 2020; status: recruiting.
02
Drugs
taurine
03
Conditions
maternally inherited diabetes and deafness (MIDD)
Beyond the preview
Go deeper on jRCT2061190026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061190026.